Sterling Investment Advisors, Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Sterling Investment Advisors, Ltd.

$426 Million
Q2 2025

A detailed history of Sterling Investment Advisors, Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Investment Advisors, Ltd. holds 3,697 shares of REGN stock, worth $2.06 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

3,697

Previous 3,712 0.4%

Holding current value

$2.06 Million

Previous $2.35 Million 17.59%

% of portfolio

0.46%

Previous 0.61%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	SELL	$483.07 - $625.6 $7,246 - $9,384	-15 Reduced 0.4%	3,697 $1.94 Million
Q1 2025 May 07, 2025	SELL	$634.14 - $744.83 $31,707 - $37,241	-50 Reduced 1.33%	3,712 $2.35 Million
Q4 2024 Feb 04, 2025	BUY	$701.85 - $1046.91 $501,822 - $748,540	715 Added 23.47%	3,762 $2.68 Million
Q3 2024 Oct 24, 2024	SELL	$1024.09 - $1201.76 $286,745 - $336,492	-280 Reduced 8.42%	3,047 $3.2 Million
Q2 2024 Aug 05, 2024	SELL	$883.2 - $1071.19 $22,080 - $26,779	-25 Reduced 0.75%	3,327 $3.5 Million
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $103,809 - $114,235	-115 Reduced 3.32%	3,352 $3.23 Million
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $54,262 - $61,719	-70 Reduced 1.98%	3,467 $3.05 Million
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $150,506 - $178,525	-215 Reduced 5.73%	3,537 $2.54 Million
Q1 2023 Apr 25, 2023	BUY	$680.49 - $826.97 $217,076 - $263,803	319 Added 9.29%	3,752 $3.08 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $105,883 - $114,958	-150 Reduced 4.19%	3,433 $2.48 Million
Q3 2022 Nov 03, 2022	SELL	$573.97 - $724.32 $143,492 - $181,080	-250 Reduced 6.52%	3,583 $2.47 Million
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $87,736 - $118,214	-160 Reduced 4.01%	3,833 $2.27 Million
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $107,121 - $125,717	-180 Reduced 4.31%	3,993 $2.79 Million
Q4 2021 Feb 02, 2022	SELL	$543.48 - $670.97 $19,565 - $24,154	-36 Reduced 0.86%	4,173 $2.64 Million
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $6,314 - $7,490	11 Added 0.26%	4,209 $2.55 Million
Q2 2021 Jul 29, 2021	BUY	$472.8 - $558.54 $139,476 - $164,769	295 Added 7.56%	4,198 $2.35 Million
Q1 2021 May 04, 2021	BUY	$446.73 - $548.2 $1.73 Million - $2.12 Million	3,875 Added 13839.29%	3,903 $1.85 Million
Q4 2020 Jan 21, 2021	SELL	$478.3 - $607.98 $47,830 - $60,798	-100 Reduced 78.13%	28 $14,000
Q3 2020 Oct 26, 2020	SELL	$544.75 - $658.21 $490,275 - $592,389	-900 Reduced 87.55%	128 $72,000
Q1 2020 Apr 30, 2020	BUY	$336.18 - $494.43 $336,180 - $494,430	1,000 Added 3571.43%	1,028 $501,000
Q4 2019 Feb 10, 2020	SELL	$274.13 - $376.51 $82,239 - $112,953	-300 Reduced 91.46%	28 $10,000
Q3 2019 Oct 15, 2019	SELL	$273.46 - $318.39 $13,672 - $15,919	-50 Reduced 13.23%	328 $91,000
Q4 2017 Jan 29, 2018	BUY	$358.63 - $469.95 $35,863 - $46,995	100 Added 35.97%	378 $142,000
Q2 2017 Aug 09, 2017	BUY	N/A	278	278 $137,000

Others Institutions Holding REGN

# of Institutions

1,398

Shares Held

85.3M

Call Options Held

1.39M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $59.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.

Account

Sterling Investment Advisors, Ltd. Regeneron Pharmaceuticals, Inc. Transaction History